EORTC-1203 GITC "INNOVATION": Integration of Trastuzumab (T), with or Without Pertuzumab (P), into Perioperative Chemotherapy of HER-2 Positive Stomach Cancer: Overall Survival Results.
Journal of Clinical Oncology(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined